ANI Pharmaceuticals to Discuss Third Quarter 2021 Financial Results on November 1, 2021
October 29, 2021BAUDETTE, Minn.–(BUSINESS WIRE)–ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2021 financial results on Monday, November 1, 2021.
Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:
|
Date |
Monday, November 1, 2021 |
|||
|
Time |
8:30 a.m. ET |
|||
|
Toll free (U.S.) |
877-876-9173 |
|||
|
Webcast (live and replay) |
www.anipharmaceuticals.com, under the “Investors” section |
|||
A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for one-week by dialing 800-938-2243 and entering access code 6513021.
About ANI
ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.
Contacts
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: [email protected]